Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
First Opinion
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Mass. Gov. Charlie Baker’s plan to curb drug prices strains his relationship with biotechs

By Priyanka Dayal McCluskey — Boston GlobeJuly 11, 2019

Reprints
Mass. Gov. Charlie Baker (right) attending the 2015 annual meeting of the Kendall Square Association in Cambridge, Mass., seated next to Dr. J.C. Gutierrez-Ramos, who was then a group vice president at Pfizer. Wendy Maeda/The Boston Globe

Massachusetts’ booming biotech industry has long enjoyed a tight — some would say coddling — relationship with lawmakers on Beacon Hill. The state has invested hundreds of millions of taxpayer dollars to help life sciences companies grow.

Suddenly, the relationship is more complicated.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Priyanka Dayal McCluskey — Boston Globe

Tags

How Tennessee is creating new opportunities for doctors trained…
How Tennessee is creating new opportunities for doctors trained outside the U.S.
Are people really falling ill from touching fentanyl? In…
Are people really falling ill from touching fentanyl? In most cases, scientists say no
Flawed herpes testing leads to many false positives —…
Flawed herpes testing leads to many false positives — and needless suffering
‘Extraordinary’ survival data for lung cancer patients is seen…
‘Extraordinary’ survival data for lung cancer patients is seen as boost for AstraZeneca drug
Targeted drug greatly slows progression of a brain cancer
Targeted drug greatly slows progression of a brain cancer
Immunogen drug prolongs survival of women with advanced ovarian…
Immunogen drug prolongs survival of women with advanced ovarian cancer

Recommended Stories